Business Context and Reporting Period
Company: Bruker BioSciences Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: April 23, 2004
Event: Pricing of a public offering of common stock.
Key Financial Metrics
This filing reports on a capital raise event rather than operational financial performance. Specific metrics include:
- Shares Offered: 15,000,000 total shares.
- Offering Price: $4.50 per share.
- Company Proceeds: Approximately $12.6 million (from the sale of 3,000,000 shares).
- Selling Stockholder Proceeds: Approximately $50.5 million (from the sale of 12,000,000 shares by four stockholders).
- Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide a clear value for these operational metrics.
Material Changes
The primary material change is the increase in the company's cash position due to the net proceeds of approximately $12.6 million from the primary offering. Additionally, the ownership structure has changed due to the secondary sale of 12,000,000 shares by existing stockholders.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the pricing of the offering but does not include specific forward-looking guidance, outlook, or management commentary regarding future operations beyond the transaction details.
Risks and Contingencies: The filing text does not provide a clear value or specific discussion of risks, contingencies, or unusual items related to this transaction.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received by the company versus the estimated $12.6 million.
- Confirm the identity of the four selling stockholders and their remaining ownership percentage post-transaction.
- Review the attached press release (Exhibit 99.1) for details on the intended use of the $12.6 million in proceeds.
- Check subsequent filings for any underwriting discounts or commissions that may affect the final net proceeds.